Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a β-lactam-mediated SOS response

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 37-45

  Cuirolo, Arabela ^a   Plata, Konrad ^a,b   Rosato, Adriana E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

MecA; Mutation rate; Oxacillin

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CEFTAZIDIME; LEXA PROTEIN; NAFCILLIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; RECA PROTEIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL GROWTH; CONCENTRATION RESPONSE; DISK DIFFUSION; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMS; DNA REPAIR ENZYMES; GENE EXPRESSION PROFILING; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOS RESPONSE (GENETICS); STRESS, PHYSIOLOGICAL;

EID: 67249101877     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp164     Document Type: Article

References (33)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Herold BC, Immergluck LC, Maranan MC et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-8.
3. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
4. Ito T, Katayama Y, Asada K et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1323-36.
5. Ito T, Ma XX, Takeuchi F et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48: 2637-51.
6. Witte W, Pasemann B, Cuny C. Detection of low-level oxacillin resistance in mecA-positive Staphylococcus aureus. Clin Microbiol Infect 2007; 13: 408-12.
7. Forbes BA, Bombicino K, Plata K et al. Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains. Diagn Microbiol Infect Dis 2008; 61: 387-95.
8. Swenson JM, Lonsway D, McAllister S et al. Detection of mecA mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn Microbiol Infect Dis 2007; 58: 33-9.
9. Finan JE, Rosato AE, Dickinson TM et al. Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob Agents Chemother 2002; 46: 24-30.
10. Oliver A, Baquero F, Blazquez J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: Molecular characterization of naturally occurring mutants. Mol Microbiol 2002; 43: 1641-50.
11. Fernandez De Henestrosa AR, Ogi T, Aoyagi S et al. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol Microbiol 2000; 35: 1560-72.
12. Little JW. LexA cleavage and other self-processing reactions. J Bacteriol 1993; 175: 4943-50.
13. Bannerman TL, Hancock GA, Tenover FC et al. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995; 33: 551-5.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteen Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
15. Reynolds PE, Brown DF. Penicillin-binding proteins of β-lactam-resistant strains of Staphylococcus aureus. Effect of growth conditions. FEBS Lett 1985; 192: 28-32.
16. Chambers HF, Archer G, Matsuhashi M. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrob Agents Chemother 1989; 33: 424-8.
17. Driffield K, Miller K, Bostock JM et al. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 2008; 61: 1053-6.
18. Goldstein F, Perutka J, Cuirolo A et al. Identification and phenotypic characterization of a β-lactam-dependent, methicillin-resistant Staphylococcus aureus strain. Antimicrob Agents Chemother 2007; 51: 2514-22.
19. Rosato AE, Kreiswirth BN, Craig WA et al. mecA-blaZ corepressors in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2003; 47: 1460-3.
20. Maiques E, Ubeda C, Campoy S et al. β-Lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J Bacteriol 2006; 188: 2726-9.
21. McKinney TK, Sharma VK, Craig WA et al. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and β-lactamase regulators. J Bacteriol 2001; 183: 6862-8.
22. Ubeda C, Maiques E, Knecht E et al. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol Microbiol 2005; 56: 836-44.
23. Hackbarth CJ, Miick C, Chambers HF. Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1994; 38: 2568-71.
24. Ender M, McCallum N, Berger-Bachi B. Impact of mecA promoter mutations on mecA expression and β-lactam resistance levels. Int J Med Microbiol 2008; 298: 607-17.
25. Sweetman WA, Moxon ER, Bayliss CD. Induction of the SOS regulon of Haemophilus influenzae does not affect phase variation rates at tetranucleotide or dinucleotide repeats. Microbiology 2005; 151 2751-63.
26. Cirz RT, Chin JK, Andes DR et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005; 3: Pe176.
27. Palom Y, Suresh KG, Tang LQ et al. Relative toxicities of DNA cross-links and monoadducts: New insights from studies of decarbamoyl mitomycin C and mitomycin C. Chem Res Toxicol 2002; 15: 1398-406.
28. Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: A review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 1995; 15: 279-91.
29. Venezia RA, Domaracki BE, Evans AM et al. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 2001; 48: 375-81.
30. Chambers HF, Archer GL, Fawcett P et al. Fluoroquinolone (FQ) enhanced expression of resistance phenotype of methicillin resistant Staphylococcus aureus (MRSA). In: Abstracts of the Forty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA, 2005. Abstract A-1746. American Society of Microbiology, Washington, DC, USA.
31. Miller C, Thomsen LE, Gaggero C et al. SOS response induction by β-lactams and bacterial defense against antibiotic lethality. Science 2004; 305: 1629-31.
32. Miller C, Ingmer H, Thomsen LE et al. DpiA binding to the replication origin of Escherichia coli plasmids and chromosomes destabilizes plasmid inheritance and induces the bacterial SOS response. J Bacteriol 2003; 185: 6025-31.
33. Perez-Capilla T, Baquero MR, Gomez-Gomez JM et al. SOS-independent induction of dinB transcription by β-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol 2005; 187: 1515-8.